Over 40 years of international experience in the field of global health.Jean-François de Lavison worked in the pharmaceutical industry for 29 years, holding various several international positions and participating in its international expansion in Europe, Asia, the Middle-East, Africa, and Latin America. He was appointed VP, in charge of Global Health and International Affairs at bioMérieux and in the Institut Mérieux Alliance. During the same period, he was Treasurer of the well known Mérieux foundation. He has been elected President of the European Diagnostic Manufacturers Association (EDMA), the organization that represents the European in vitro diagnostics industry on a worldwide level. He was a member of the Executive Committee of Stop TB Partnership, and the focal point of the private sector constituency. He was a member of the Global Fund private sector constituency. Through his extensive international experience in both developed and developing countries, Jean-François has acquired unique skills in the field of global health. His strong commitment to providing a response to the urgent needs of emerging countries prompted to the launch of Ahimsa Partners in January 2010. Ahimsa Partners’ objective is to engage, through a dynamic Global Health Diplomacy, the various stakeholders in the global health landscape, in order to establish innovative initiatives throughout the world. Jean-François is the founder and President of Ahimsa Fund, a non-profit organization (endowment fund) whose objective is to make good health contagious accessible to the most vulnerable populations. Ahimsa Fund focuses on the world’s most underprivileged populations and develops realistic, innovative, cost-effective and replicable public health initiatives with the objective of empowering the local population. “Such an approach must reinforce the idea that our differences are strengths on which we must build our future, not weaknesses behind which we have to hide.” (JF de Lavison).Jean-François is currently a member of :the board of the Health Innovation Exchange (UNAIDS initiative);the Steering Committee for the Social Innovation in Health contest of the London School of Hygiene and Tropical Medicine (TDR/WHO initiative);the Global Health jury for the Impact Hub Geneva Accelerate2030 program;the Steering Committee of the Faith and HIV in the Next Decade initiative.Member of the Board Hemex Heath US)Member of the Board miDiagnostics (Belgium)